Gold Royalty Corp. GROY 深 沪
已收盘 07-02 16:00:00 美东时间
2.86
+0.100
+3.62%
华盛通- 最 高2.93
- 今 开2.85
- 成交量 180.90万股
- 最 低 2.805
- 昨 收 2.76
- 总市值 6.60亿
- 52周最高 5.4547
- 市盈率 静 --
- 换手率 0.78%
- 52周最低 2.37
- 委 比 37.06%
- 总股本 2.31亿
- 历史最高 7.02
- 量 比 1.22
- 振 幅 4.53%
- 历史最低 1.16
- 每 手 1
- 风险率 0.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gold Royalty Corp Increases REN Project Royalty Interest To 1.6875% NSR For $6.25M, Expanding Exposure To Nevada Gold Mine Development; Expected To Produce 140,000 Ounces Annually By Year-End 2027
Gold Royalty Corp Increases REN Project Royalty Interest To 1.6875% NSR For $6.25M, Expanding Exposure To Nevada Gold Mine Development; Expected To Produce 140,000 Ounces Annually By Year-End 2027
06-16 05:06
Gold Royalty Corp. Projects Strong, Debt-Free Growth
Gold Royalty Corp. (($GROY)) has held its Q1 earnings call. Read on for the mai...
05-20 16:09
Elemental Royalty to buy Vizsla Royalties in $239M deal
Elemental Royalty (ELE) said Thursday it agreed to acquire Vizsla Royalties for C$327M (US$239M), creating "a platform of cash-flowing and near-term development royalties with long-term growth potenti...
05-14 19:19
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Gold Royalty Corp. Projects Strong Growth Ahead
Gold Royalty Corp. (($GROY)) has held its Q1 earnings call. Read on for the mai...
05-08 09:29
HC Wainwright & Co. Maintains Buy on Gold Royalty, Raises Price Target to $7.75
HC Wainwright & Co. analyst Heiko F. Ihle maintains Gold Royalty (AMEX:GROY) with a Buy and raises the price target from $6.75 to $7.75.
05-08 03:09
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
Canaccord Genuity Upgrades Gold Royalty to Buy, Maintains Price Target to $5
Canaccord Genuity analyst Carey MacRury upgrades Gold Royalty (AMEX:GROY) from Hold to Buy and maintains the price target from $5 to $5.
04-29 23:53
